M. Huber

Phase I evaluation of all-trans-retinoic acid in adults with solid tumors.

S. Lippman, W. Hong, R. Newman, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy.

R. A. Robinson, S. Lippman, J. Lee, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre.

D. Ettinger, E. Shaw, M. Tucker, 1997, Journal of the National Cancer Institute.

Warfarin and small-cell lung cancer.

W. Hong, M. Huber, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary therapy of multiple myeloma with paclitaxel (taxol).

M. Dimopoulos, S. Arbuck, D. Weber, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase I investigation of the sequential use of methotrexate and paclitaxel with and without G-CSF for the treatment of solid tumors.

S. Lippman, W. Hong, F. Fossella, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Biology and chemoprevention of head and neck cancer.

W. Hong, M. Huber, M. Huber, 1994, Current problems in cancer.

Current Status of Clinical Trials with Paclitaxel and Docetaxel

J. Ajani, V. Valero, A. Kudelka, 1994 .

Biology and reversal of aerodigestive tract carcinogenesis.

S. Lippman, W. Hong, G. Clayman, 1995, Cancer treatment and research.

Chemoprevention of lung cancer.

J. Lee, W. Hong, M. Huber, 1993, Seminars in oncology.

Phase I study of paclitaxel, cisplatin, and ifosfamide in patients with recurrent or metastatic squamous cell cancer of the head and neck.

S. Lippman, W. Hong, S. Benner, 1995, Seminars in Oncology.